Caricamento...
Fluconazole resistance in Candida species: a current perspective
Candida albicans and the emerging non-albicans Candida spp. have significant clinical relevance among many patient populations. Current treatment guidelines include fluconazole as a primary therapeutic option for the treatment of these infections, but it is only fungistatic against Candida spp. and...
Salvato in:
| Pubblicato in: | Infect Drug Resist |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546770/ https://ncbi.nlm.nih.gov/pubmed/28814889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S118892 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|